InsiderTrades

Form 4 for LLY Lilly (Eli)

Accepted 2026-08-03 16:42:34 ET · period of report 2026-08-01 · accession 0002032089-26-000002 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2026-08-03 16:42 2026-08-01 LLY Seymour Melissa EVP, Gbl Quality M - OptEx $0.00 +981 1,506 +187% $0
D 2026-08-03 16:42 2026-08-01 LLY Seymour Melissa EVP, Gbl Quality F - Tax $1,148.84 -438.71 1,067 -29% -$504.0K
D 2026-08-03 16:42 2026-08-01 LLY Seymour Melissa EVP, Gbl Quality M - OptEx $0.00 -981 952 -51% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-08-01 M A 981 $0.00 1,506.08 D — —
2 Common Common Stock 2026-08-01 F D 438.71 $1,148.84 1,067.37 D — —
3 Derivative Restricted Stock Unit 2026-08-01 M D 981 $0.00 952 D — · — to — 981 Common Stock (F1) Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. (F2) The restricted stock units vest in three installments, 952 on August 1, 2025, 981 on August 1, 2026, and 952 on August 1, 2027. (F2) The restricted stock units vest in three installments, 952 on August 1, 2025, 981 on August 1, 2026, and 952 on August 1, 2027.